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ABSTRACT 
CD4 count is an important immunological marker of disease progression in HIV seropositive 
patients. This study was carried out to determine the effect of malaria or fever of unknown 
origin on the population of CD4+ T lymphocytes of HIV seropositive patients attending the 
highly active antiretroviral therapy (HAART) clinic of the University of Ilorin Teaching Hos-
pital, Ilorin, Nigeria. 36 subjects were selected for this study. Ongoing history of fever was 
used as a case definition for malaria and malaria was confirmed from microscopic examina-
tion of thick and thin film of blood sample obtained from the patients during presentation with 
fever. The CD4 count was evaluated during presentation of fever and post-fever using flow 
cytometry. There was significant decrease in CD4 count of the patients. However, upon clas-
sifying the patients into 2 groups – those that returned to the clinic after a week and those that 
returned after a month; a significant increase in CD4 count was noticed in the group that re-
turned after a week, while a significant decrease was noticed in the group that returned after a 
month (at p value of 95 %). Further classification of the patients based on presence of malaria 
parasite, and body temperature resulted in varying effects on CD4 count post-fever (in the 
general group, 27 were positive for malaria parasites). Of these 27, there was an increase in 
CD4 count in 9 (33.3 %).  However in the group that returned after a week, all 6 (100 %) that 
were positive for malaria parasites showed increase in CD4 count. Five (26.3 %) of the 
19 patients that had body temperature within the range of 35.5-37.4 °C showed an increase in 
CD4 count, while 7 (41.2 %) of the 17 patients that had body temperature of 37.5 °C and 
above showed an increase in CD4 count. The results led to the conclusion that while some 
components of the immune response to malaria could strengthen the immune system of HIV 
seropositive patients by increasing their CD4 count, other components will suppress their 
immunity by decreasing their CD4 count, accelerating the progression to AIDS. 
Keywords: CD4 Count, HIV/AIDS, CD4+ T lymphocytes, flow cytometry, malaria, immune 
system 
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Human Immunodeficiency Virus (HIV) 
is the etiologic agent of the disease known 
as acquired immune deficiency syndrome 
(AIDS). It causes a progressive impairment 
of the body’s cellular immune system by 
destroying CD4+ T cells, leading to in-
creased susceptibility to various infections. 
HIV/AIDS is a major public health problem 
with socio-economic burden and a serious 
threat to development (Bell et al., 2003). 
Nine out of 10 people living with HIV 
are in the developing world (Pickrell, 
2005). 60 to 70 % of those are in Sub-
Saharan Africa. But the disease is spreading 
in every region, with fierce epidemics 
threatening to tear through countries such 
as India, China, Russia and the islands of 
the Caribbean. As HIV spreads, it interacts 
with other infectious diseases, facilitated by 
the increase in numbers of immunosup-
pressed individuals. These interactions can 
alter the clinical course of both diseases.  
Malaria is by far the world's most im-
portant tropical parasitic disease, and kills 
more people than any other communicable 
disease except tuberculosis (WHO, 2006). 
Malaria is a public health problem today in 
more than 90 countries, inhabited by a total 
of some 2.4 billion people – 40 % of the 
world's population. Malaria is endemic in a 
total of 101 countries and territories, most 
of them in Africa.  
In Africa, the HIV pandemic has been 
superimposed on the longstanding malaria 
infection which is endemic, where P. falci-
parum malaria is consistently one of the 
major causes of infant and child mortality. 
The high prevalence of both HIV and ma-
laria infection in Africa means that even 
small interactions between the two could 
have substantial effects on populations 
(UNICEF, 2003). In more recent years, one 
of the key issues on the relationship be-
tween malaria infection and HIV/AIDS has 
focused on the effect of malaria on CD4 
count of HIV patients. 
The main question is whether malaria 
infection accelerates progression of 
HIV/AIDS or improves the immune level 
of the patient and is somehow protective. 
Many interesting studies have been con-
ducted on the relationship between these 
two potentially fatal diseases, but a general 
consensus is yet to be reached on the ef-
fects, if any, of malaria parasitaemia on the 
underlying HIV infection in patients. 
Studies conducted by Whitworth and 
Hewitt (2005) seemed to suggest that malar-
ial infection leads to an increase in the HIV 
viral load, thereby potentially hastening the 
progression of HIV to full blown AIDS. 
The findings in that study indicated that this 
increased viral load was reversed by effec-
tive malaria treatment. Other researchers 
have reported an increase in the CD4+ 
counts of HIV patients during the course of 
malarial infection (Heimlich, 2002). The 
latter group has hinted at the possibility of 
repeatedly inducing malaria in HIV patients 
so as to boost their immunity and prevent 
the progression to AIDS. This is referred to 
as malariotherapy, a treatment reminiscent 
of what was done for neurosyphilis in the 
1920s by the Austrian doctor, Wagner 
Jauregg (Heimlich, 2002). 
Plasmodium falciparum infection is en-
demic in most tropical countries and will 
definitely infect HIV patients living in this 
region at one time or the other. Hence, it is 
important to determine the effect malaria 
parasites will have on the quality of life of 
HIV patients, especially since other infec-
tions in HIV patients are being effectively 
controlled. 
 
MATERIALS AND METHODS 
 
Study area 
The study was carried out at the University 
of Ilorin Teaching Hospital (UITH), a terti-
ary and referral hospital located in Ilorin, 
the Kwara state capital. It is a 486-bed hos-
pital (University of Ilorin Teaching Hospi-
tal, 2000) involved in teaching, research 
and training of medical students and resi-
dent doctors. It is an affiliate of University 
of Ilorin through, the College of Health Sci-
ences. 
 
EXCLI Journal 2010;9:58-66  ISSN 1611-2156 




Thirty-six HIV seropositive patients that 
presented with fever were recruited in this 
study following approval by the Ethics and 
research committee of the Hospital and due 
consent of the patients. Based on the sam-
ple size of this study, the subjects had to be 
grouped into two broad temperature catego-
ries, for proper statistical analysis. The tem-
perature ranges were 35.5 °C-37.4 °C and 
37.5 °C-39.8 °C. 
 
Blood collection 
Aseptic procedures were adopted in the 
collection of the blood samples. 5 ml of ve-
nous blood was obtained using sterile nee-
dle and syringe and dispensed into EDTA 
bottles (Imade et al., 2005). 
 
CD4+ T cell count 
CD4 counts of the patients were evalu-
ated during fever and post-fever using a 
Partec flow cytometer. 20 µl of whole 
blood was placed in a rohren tube, and 
20 µl of CD4+ T cell monoclonal antibod-
ies was added. The tube was then incubated 
in the dark for 15 minutes at room tempera-
ture after which 800 µl of buffer was added. 
The tube was placed in the Partec flow cy-
tometer. The value of CD4+ T cells per ml 
in the sample of blood was then obtained 
from a programmed computer connected to 
the instrument (Imade et al., 2005).  
 
Preparation of thin and thick blood film 
The preparation of both thick and thin 
blood films for confirmation of parasitae-
mia were carried out using the methods de-
scribed by Cheesbrough (2005).  
 
Microscopic examination 
A drop of immersion oil was placed on 
the stained thin film and another drop on 
thick film. They were examined systemati-
cally using x 100 objectives (oil immersion 
objective). Identification was done by the 
method described by Cheesbrough (2005).  
 
Statistical methods 
The variation in CD4 count during and 
after episodes of malaria and fever are 
given as percentage proportion. Variations 
were categorized as increase and decrease. 
Differences between the categories were 
analyzed by T-test of equality in proportion.  
In order to determine if any significant 
variation in CD4 count is due to the action 
of malaria parasite or fever, patients were 
examined for malaria parasite. The observa-
tions were analyzed for significance using 
T-Test of equality of proportion, a two-way 





There was a decrease in the mean dif-
ference of the CD4 count of the patients 
(p<0.05). Of the total 36 samples evaluated, 
a decrease in the value of CD4+ T lympho-
cytes was observed in 24 (66.7 %) samples, 
while an increase was noticed in the re-
maining 12 (33.3 %) samples (p<0.05). 
However, when the subjects were divided 
into 2 groups based on the time of their re-
turn to the clinic (10 returned after a week 
while the remaining 26 returned after a 
month), the result varied. There was an in-
crease in the CD4 count of the patients 1 
week post-fever presentation when com-
pared with the count obtained at fever pres-
entation (p<0.05). Of the 10 samples evalu-
ated, an increase was noticed in 8 (80 %), 
while a decrease in the value of CD4+ T 
lymphocytes was observed in the 2 (20 %) 
remaining samples (p<0.05). The CD4 
counts of 26 patients were evaluated during 
fever, and 1 month post-fever presentation. 
Those that returned after a month had a de-
crease in the mean values of the CD4 count 
(p<0.05). Of these 26 patients, 22 (84.6 %) 
showed a decrease in CD4 count, while the 
remaining 4 (15.4 %) showed an increase in 
CD4 count (Table 1).  
There was also variation in CD4 count 
of the subjects in relation to presence of 
malaria parasite. Of the 36 patients in-
volved in this study, 27 were positive for 
malaria parasites. Of the 27 samples that 
were positive for malaria parasite, there was 
an increase in CD4 count in 9 (33 %), while 
there was a decrease in CD4 count in 18 
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(p<0.05). Also, of the 9 samples that were 
negative for malaria parasite, 3 (33.3 %) 
showed an increase in CD4 count, while 6 
(66.7 %) showed a decrease in CD4 count. 
Statistically, the difference in the blood ma-
laria status, in patients that showed increase 
in CD4 count was significant (p<0.05) (Ta-
ble 2).  
When the variation in CD4 count in re-
lation to malaria parasite in patients that 
reported back to the clinic after a week was 
checked, 6 of the 10 of them were positive 
for malaria parasite, while the remaining 4 
were negative (Table 3). All 6 (100 %) pa-
tients that were positive for malaria parasite 
showed an increase in CD4 count. Of the 4 
that were negative for malaria parasite, 2 
(50 %) showed an increase in CD4 count, 
while the remaining 2 (50 %) showed a de-
crease. Statistically, the difference in the 
blood malaria status, in patients that 
showed increase in CD4 counts was signifi-
cant (p< 0.05).  
Body temperature during fever did not 
have a significant influence on variation in 
CD4 count in the overall group (p<0.05) 
(Table 4). It must be noted that for some of 
the subjects, their body temperature was 
below 37.5 °C, which is the body tempera-
ture indicative of fever. Nineteen patients 
had body temperature within the range of 
35.5-37.4 °C, while 17 had body tempera-
ture of 37.5 °C and above. Of the 19 patients 
that had body temperature within the range 
of 35.5-37.4 °C, 5 (26.3 %) showed an in-
crease in CD4 count, while 14 (73.7 %) 
showed a decrease. Of the 17 patients that 
had body temperature of 37.5 °C and above, 
7 (41.2 %) showed an increase in CD4 
count while 10 (58.8 %) showed a decrease. 
The difference was not statistically signifi-
cant (p> 0.05).  
 
 
Table 1: Values of CD4+ T cells in HIV seropositive patients during fever and post-fever presen-
tation 
 
Health Status Samples Increase in CD4 count Decrease in CD4 count 
General 36 12 (33.3 %) 24 (66.7 %) 
1 week post-fever 10 8  (80.0 %) 2 (20.0 %) 
1 month post-fever 26 22 (84.6 %) 4 (15.6 %) 
 
Table 2: Influence of blood malaria status on variation in CD4 counts in HIV patients after pres-
entation with fever 
 
Malaria Parasite Increase in CD4 count 
(Mean difference) 
Decrease in CD4 count 
(Mean difference) 
Positive  9 (168.1)  18 (120.2) 
Negative  3 (20.3)  6 (109.7) 
 
Table 3: Influence of blood malaria status on variation in CD4 counts 1 week after presentation 
with fever 
 
Malaria Parasite Increase in CD4 count 
(Mean difference) 
Decrease in CD4 count 
(Mean difference) 
Positive  6 (171)  0 
Negative  2 (27)  2 (195.5) 
 
Table 4: Influence of body temperature on variations in CD4 counts during fever, and after 
presentation with fever in HIV seropositive patients 
 
Temperature count (°C) Increase in CD4 count 
(Mean difference) 
Decrease in CD4 count 
(Mean difference) 
35.5-37.4  5 (109)  14 (126.4) 
37.5-39.8  7 (153.4)  10 (99.0) 
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Ten patients returned after a week. Of 
these ten, three had body temperature 
within the range of 35.5-37.4 °C, while 7 
had body temperature of 37.5 °C and above. 
Of these total of 10 patients, 8 had increase 
in CD4+ T cells, while the remaining 2 had 
a decrease. Three out of the 8 that had an 
increase in CD count had body temperature 
within the range of 35.5-37.4 °C. The re-
maining 5 had body temperature of 37.5 °C 
(p<0.05) (Table 5). Of the 26 remaining 
patients that returned after a month, 16 pa-
tients had body temperature within the 
range of 35.5-37.4 °C, while 10 had body 
temperature of 37.5 °C and above. Of the 
16 patients that had body temperature 
within the range of 35.5-37.4 °C, 2 showed 
an increase in CD4 count, while 14 showed 
a decrease. Of the 10 patients that had body 
temperature of 37.5 °C and above, 
2 showed an increase in CD4 count while 
8 showed a decrease. The mean difference 
was statistically significant (p< 0.05) (Ta-




This work has attempted to provide an-
swers to some controversial issues of the 
consequence of malaria parasite infection in 
HIV seropositive individuals. It is not 
known whether malaria accelerates the pro-
gression of HIV to full-blown AIDS or 
ameliorates HIV infection by fever-
inducing mechanism. To achieve this, the 
CD4+ T cell counts of the blood samples 
obtained from the 36 patients that partici-
pated in this study were evaluated during, 
and after episodes of malaria and fever of 
non-malarial origin. Ongoing history of fe-
ver was used as a clinical definition of ma-
laria and malaria was confirmed from mi-
croscopic examination of thin and thick 
film.  
There were variations in the CD4 cell 
count, during and after fever, in all 36 pa-
tients, and the pattern of variation differed 
based on the different groups of the patients 
(Table 1). While some patients had in-
creased CD4 counts post-fever, others 
showed a decrease. The variations in CD4 
counts observed in this work are concomi-
tant to similar studies that had been carried 
out previously, confirming the fact that ma-
laria does have an effect on the underlying 
infection in HIV seropositive patients. 
Heimlich (2002), Whitworth et al. (2000) 
and Mermin et al. (2006) all noted changes 
in the CD4 counts of HIV seropositive pa-




Table 5: Influence of body temperature on variations in CD4 counts during fever, and one week 
after presentation with fever in HIV seropositive patients 
 
Temperature count (°C) Increase in CD4 count 
(Mean difference) 
Decrease in CD4 count 
(Mean difference) 
35.5-37.4  3 (94.1)  0 
37.5-39.8  5 (160.2)  2 (195.5) 
 
 
Table 6: Influence of body temperature on variations in CD4 counts during fever, and one 
month post-fever presentation in HIV seropositive patients 
 
Temperature count (°C) Increase in CD4 count 
(Mean difference) 
Decrease in CD4 count 
(Mean difference) 
35.5-37.4  2 (109.0)  14 (126.3) 
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Generally, a decrease in CD4 count was 
observed in this study (Table 1). This seems 
to support the claims of Whitworth et al., 
2000) and Hviid et al., 1991). Hviid re-
ported that malaria-specific T cell responses 
and even unrelated T cell responses are 
downregulated during the course of malaria 
infection (Hviid et al., 1991). The study 
carried out by Whitworth et al. (2000) fo-
cused on the viral load of HIV patients that 
participated. They reported an increase in 
the viral load of the patients following epi-
sodes of malaria. Increase in viral load, if 
sufficient enough, will cause a decrease in 
CD4 count. This could also be responsible 
for the decrease in CD4 count noticed in 
this study. 
Some of the patients that participated in 
this study returned after a week while the 
rest returned after a month. A significant 
increase in CD4 count was noticed in the 
group that returned after a week (p<0.05). 
This is concomitant with Heimlich (2002), 
in which an increase in CD4 count in HIV 
patients infected with malaria parasites was 
reported. The presence of malaria parasite 
increases production of cytokines by the 
immune system in an effort to ward off the 
invading organism. The cytokines produced 
can also activate CD4+ T lymphocytes, 
strengthening the immune system (Heim-
lich, 2002). This could account for the in-
crease in CD4 count noticed in this group, 
and this observation seems to lend credence 
to Heimlich’s argument that malaria can be 
used in boosting the immunity of HIV pa-
tients, a procedure termed “malariother-
apy”. 
However, in the group that returned af-
ter a month, there was significant decrease 
in CD4 count post-fever, indicating possi-
ble acceleration of HIV infection towards 
AIDS. This result seems to confirm the ob-
servation reported by Whitworth and Hew-
itt (2005). It was observed that an increase 
in HIV load could eventually lead to a de-
crease in CD4 count. This could have been 
as a result of the action of pro-inflammatory 
cytokine such as TNF-α. P. falciparum has 
been shown to stimulate HIV-1 replication 
through the production of cytokines such as 
TNF-α and interleukin-6 (Froebel et al., 
2004).  
The results observed above (Table 1) 
suggest that the various components of the 
immune response mounted to challenge the 
presence of malaria parasites in the body 
will have varying effects on the T lympho-
cyte population of the patients that partici-
pated in this study. Cytokines have been 
reported to exert multiple actions that affect 
the activity of multiple cell types (Ozaki 
and Leonard, 2002). This is referred to as 
cytokine pleiotropy. TNF-α and IL-10, 
which have been reported to be produced 
during malarial disease (Lyke et al., 2004), 
have varying effects on different cell types, 
and at different times (Moore et al., 1993). 
Differences in the quality of variation ob-
served in these 2 groups suggest that the 
pleiotropic nature of some of the cytokines 
involved in the immune response of the 
body to malaria may have had varying ef-
fects on the population of CD4+ T cells.  
Some patients that participated in this 
study had low level of parasitaemia as ob-
served from the microscopic examination of 
their blood film (Table 2). TNF-α has been 
reported to be involved in the cell mediated 
immune response against malaria, prevent-
ing parasitaemia by stimulating neutrophils 
and monocytes to phagocytosize parasites 
(Karunaweera et al., 2003; Clark et al., 
2006). This could account for the level of 
parasitaemia in patients in this group. There 
was significant decrease in CD4 count of 
these patients. Hoffman et al. (1999) in a 
study into the effect of malaria on the viral 
load in HIV patients, noticed a significantly 
higher HIV-proviral load in patients with 
malaria than those without, and this re-
mained higher for at least 4 weeks after 
treatment. This increase in HIV load could 
lead to a decrease in CD4 count and may 
account for the decrease in CD4 count of 
patients in this group. This would suggest 
that malaria causes faster progression of 
HIV disease.  
Another bone of contention in the over-
all debate as to the effect of malaria on HIV 
is whether any noticeable effect is due to 
the presence of malaria parasites or the fe-
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ver induced during malarial disease. Com-
parison in CD4 count variation was made in 
subjects that were positive for malaria para-
sites and those that were negative (Tables 2 
and 3). There was significant increase in 
CD4 count in those that had malaria para-
sites. Davachi et al. (1991) in a study car-
ried out in a children's hospital in Kinshasa, 
Congo, followed 112 children with AIDS, 
41 of whom also had malaria. They re-
ported that none of the 41 children with ma-
laria and AIDS died. All recovered from 
their malaria. However, of the remaining 
71 children with AIDS without malaria, 25 
(35 %) died.  
A similar result was observed in pa-
tients that returned after a week (Table 3). 
All of the patients in this group who were 
positive for malaria parasite showed an in-
crease in CD4 counts. The continuous re-
lease of malarial pyrogenes that stimulate 
CD4+ T cells was lingering in those with 
malaria parasites such that there was still 
increase in CD4 count after a week as op-
posed to those who were malaria-parasite 
negative, who showed significant decrease 
in CD4 count within a week. The results 
observed in Tables 2 and 3 seem to suggest 
that malaria parasites play a key role in the 
stimulation of the immune system enough 
to produce increase in the population of 
CD4+ T lymphocytes which can be benefi-
cial to HIV patients.  
This study also attempted to investigate 
the effect of the quality of fever, as indi-
cated by body temperature, on the CD4 cell 
count during malaria and fever of other ori-
gins. Based on the sample size examined in 
this study, the subjects had to be grouped 
into two broad temperature categories, for 
proper statistical analysis. The temperature 
ranges were 35.5 °C-37.4 °C and 37.5 °C-
39.8 °C (Table 4). It must be noted that for 
some of the subjects, their body tempera-
ture was below 37.5 °C, which is the body 
temperature indicative of fever. It has been 
established that time affects the production 
of cytokines (Petrovsky and Harrison, 
1998). This is significant because the par-
oxysm associated with malaria is often ex-
perienced around evening time, while the 
temperature was taken in the morning (dur-
ing clinic). This could account for the rea-
son why some of the patients had body 
temperature less than that indicative of fe-
ver.  
In the overall group, there was no sig-
nificant variation in CD4 count of the sub-
jects based on their body temperature dur-
ing malarial disease (Table 4). This seems 
to suggest that the effect of malaria fever on 
the CD4 count of HIV positive patient does 
not depend on the quality of fever induced. 
If this is so, it reflects the results observed 
in some of the patients that underwent ma-
lariotherapy in the treatment of neuro-
syphilis. According to Heimlich (2002), 
some patients were cured even when the 
malaria did not produce high fevers.  
However, when the effect of quality of 
fever on the CD4 count of the HIV patients 
that participated in this study were analyzed 
based on the time of their return to the 
clinic post-fever, significant variations were 
noticed. In the group that returned after a 
week (Table 5), temperature had a signifi-
cant effect as more of those that had body 
temperature equal to or greater than 37.5 °C 
had an increase in CD4 count, while for the 
group that returned after a month, a signifi-
cantly higher number of them showed a de-
crease in CD4 count (Table 6). This seems 
to suggest that quality of fever may have a 
bearing on the effect of malaria fever on the 
CD4 count of HIV patients depending on 
the time interval between the peak of malar-
ial disease and the remission of fever. This 
may be as a result of the diverse nature and 
effects exerted by the cytokines involved in 
the immune response to the presence of 
pathogens. The process of fever induction 
involves the activation of CD4+ T cells by 
pyrogens (Clark et al., 2004). The acti-
vation of T-helper cells could have been 
strong enough to activate a high population 
of T cells. This activation will lead to an 
increase in CD4 count. The cytokines that 
normally induce fever were probably still 
activating CD4+ T cells in the group that 
returned after a week, as opposed to those 
that returned after a month, in which the 
effects of the fever-inducing cytokines have 
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probably worn off. This could explain the 
significant increase in CD4 count observed 
in patients with body temperature indicative 
of fever in the patients that returned after a 
week, and significant decrease in those that 
returned after a month.  
In conclusion, episodes of malaria fever 
in HIV patients elicit varying immune 
responses with attendant effect on the 
patients. It is therefore important to further 
investigate the various components of the 
immune system to malaria and the parts 
they play in the response to the presence of 
malaria parasites. Also, due to the fact that 
a significantly higher number of the 
patients eventually showed a decrease in 
CD4 count post-fever, it is imperative to 
continue the ongoing efforts to protect HIV 





We wish to appreciate the invaluable 
assistance of Mr. Popoola of the Depart-
ment of Haematology, University of Ilorin 
Teaching Hospital, Nigeria. We also appre-
ciate the Management and Staff of the Uni-
versity of Ilorin Teaching Hospital for their 




Bell C, Devarajan S, Gershach H. The long-
run economic costs of  AIDS: Theory and 
an application to South Africa. World Bank 
Working Paper 2003;No. 3152:23-45. 
 
Cheesbrough M. District laboratory practice 
in tropical countries. 2nd ed. Cambridge: 
Cambridge Univ. Press, 2005, pp 244-51.  
 
Clark IA, Budd AC, Alleva LM, Cowden 
WB. Pathogenesis of malaria and clinically 
similar conditions. Clin Microbiol Rev 
2004;17:509-39. 
 
Clark IA, Budd AC, Alleva LM, Cowden 
WB. Human malarial disease: a conse-
quence of inflammatory cytokines. Malaria 
J 2006;5:85. 
Davachi F, Kabongo L, Ngoie K. De-
creased mortality from malaria in children 
with symptomatic HIV infection. Interna-
tional Conference on AIDS 1991;7:164. 
 
Froebel K, Howard W, Schafer J. Activa-
tion by malaria antigens renders mononu-
clear cells susceptible to HIV infection and 
reactivates replication of endogenous HIV 
in cells from HIV- Sinfected adults. Para-
site Immunol 2004;26:213-7. 
 
Heimlich H. Malariotherapy: An affordable 
and accessible treatment for HIV/AIDS. 
Paper presented at the Pan Africa AIDS 
conference. (2002). 
 
Hoffman IF, Jere CS, Taylor TE, Munthali 
P, Dyer JR, Wirima JJ, Rogerson SJ, 
Kumwenda N, Eron JJ, Fiscus SA, 
Chakraborty H, Taha TE, Cohen MS, 
Molyneux ME. The effect of Plasmodium 
falciparum malaria on HIV-1 RNA blood 
plasma concentration. AIDS 1999;13:87–
94. 
 
Hviid L, Theander T, Abu Zeid Y, Abdul-
hadi N, Jakobsen P, Saeed B, Jepsen S, 
Bayoumi RA, Jensen JB. Loss of cellular 
immune reactivity during acute Plasmo-
dium falciparum malaria. FEMS Microbiol 
Immunol 1991;3:219–27. 
 
Imade GE, Badung B, Pam S, Agbaji O, 
Egah D, Sagay A. Comparison of a new, 
affordable flow cytometric method and the 
manual magnetic bead techique for CD4 T-
lymphocyte counting in a Northern Nige-
rian setting. Clin Diagn Lab Immunol 
2005;12:224-7. 
 
Karunaweera N, Wijesekera S, Wanasekera 
D, Mendis K, Carter R. The paroxysm of 
Plasmodium vivax malaria. Trends Parasitol 
2003;19:188-93. 
 
EXCLI Journal 2010;9:58-66  ISSN 1611-2156 
Received: October 14, 2009, accepted: April 18, 2010, published: April 26, 2010 
 
66 
Lyke KE, Burges R, Cissoko Y, Sangare L, 
Dao M, Diarra I, Kone A, Harley R, Plowe 
CV, Doumbo OK, Sztein MB. Serum levels 
of the proinflammatory cytokines inter-
leukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, 
tumor necrosis factor alpha, and IL-12 
(p70) in Malian children with severe Plas-
modium falciparum malaria and matched 
uncomplicated malaria or healthy controls. 
Infect Immun 2004;72:5630–7.  
 
Mermin J, Lule J, Ekwaru J. Association 
between malaria and CD4 cell count decline 
among persons with HIV. J Acquir Immune 
Defic Syndr 2006;41:129-30. 
 
Moore K, O’Garra A, De Waal Malefyr R, 
Vieira P, Mosmann T. Interleukin-10. Annu 
Rev Immunol 1993;11:165–90. 
 
Ozaki K, Leonard W. Cytokine and cyto-
kine receptor pleiotropy and redundancy. J 
Biol Chem 2002:277:29355-8.  
 
Petrovsky N, Harrison L. The chronobiol-
ogy of human cytokine production. Int Rev 
Immunol 1998;16:635-49.  
 
Pickrell J. HIV and AIDS. 
http://www.newscientist.com (2005). 
 
UNICEF. Malaria and HIV. Malaria Tech-
nical Note 6 (2003). 
 
University of Ilorin Teaching Hospital. An-
nual report 2000:5. 
 
Whitworth J, Morgan D, Quigley M, Smith 
A, Mayanja B, Eotu H, Omoding N, Ok-
ongo M, Malamba S, Ojwiya A. Effect of 
HIV-1and increasing immunosuppression 
on malaria parasitaemia and clinical epi-
sodes in adults in rural Uganda: a cohort 
study. Lancet 2000;356:1051–6. 
 
Whitworth J, Hewitt K. Effect of malaria on 
HIV-1 progression and transmission. Lan-
cet 2005;365:196-7. 
 
WHO, World Health Organization. Malaria. 
http://www.who.int.com (2006). 
